Willkie represents long-time client MedAssets in its proposed sale to Pamplona Capital Management.
On November 2, Willkie client MedAssets, Inc. announced that it has agreed to be acquired by Pamplona Capital Management for $31.35 per share in cash – an enterprise value of approximately $2.7 billion. The transaction is expected to close in the first quarter of 2016.
MedAssets (NASDAQ: MDAS) is a healthcare performance improvement company. More than 4,500 hospitals and 123,000 non-acute healthcare providers rely on MedAssets’ solutions to reduce the total cost of care, enhance operational efficiency, align clinical delivery, and improve revenue performance. Pamplona Capital Management is a London and New York-based specialist investment manager that provides an alternative investment platform across private equity, fund of hedge funds and single manager hedge fund investments.
The Willkie deal team was led by partner Steven Gartner and included partners Morgan Elwyn, Jeffrey Korn, Michael Katz and William Dye; and associates Manuel Miranda, Daniel Philion, Adam Remo, Thomas Cantore and Geri Anne McEvoy.